Table 1 Patient characteristics

n

98

71

Male

48 (49)

40 (56)

0.345

Age (y)

83 ± 5

78 ± 5

< 0.0001

BMI (kg/m²)

26 ± 5

27 ± 4

0.018

EF (%)

52 ± 13

55 ± 12

0.122

COPD

34 (35)

14 (20)

0.030

Cancer

20 (21)

15 (21)

0.480

Cerebrovascular disease

22 (22)

8 (11)

0.060

GFR pre (ml/min/1,73m²)

33 ± 12

38 ± 12

0.002

GFR post (ml/min/1,73m²)

35 ± 14

42 ± 17

0.001

PVD

32(33)

4 (6)

0.001

Hypertension

68 (70)

51 (72)

0.731

Diabetes

28 (29)

17 (24)

0.545

Smoking

13 (13)

8 (11)

0.698

Cholesterol (mmol/L)

4.7 ± 1.2

4.9 ± 1.1

0.322

PAP

40 ± 14

33 ± 10

0.001

CAD

69 (70)

42 (59)

0.323

Previous CABG

32 (33)

1 (1)

< 0.0001

New CABG

0 (0)

31 (44)

< 0.0001

Previous PCI

48 (49)

13 (18)

0.002

Pacemaker

13 (13)

5 (7)

0.252

LBBB

11 (11)

6 (9)

0.554

Heart failure < 2 weeks

80 (82)

43 (61)

0.002

CK MB post (U/L)

19 ± 58

28 ± 20

0.224

NT-proBNP (ng/L)

5416 ± 7920

1422 ± 2341

< 0.0001

NYHA III-IV pre

88 (89)

50 (70)

0.002

NYHA III-IV post

4 (6)

2 (3)

0.210

LogEuroScore

25 ± 13

10 ± 6

< 0.0001